Stock PXMD PAXMEDICA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PaxMedica, Inc.

Equities

PXMD

US70424C2035

Market Closed - OTC Markets
Other stock markets
 03:58:18 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.2968 USD +32.55% Intraday chart for PaxMedica, Inc. +43.38% -60.79%
May. 06 PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index CI
May. 01 PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
AQ
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
AQ
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index
CI
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index
CI
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
AQ
Paxmedica, Inc. Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
CI
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
AQ
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
AQ
PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
CI
Sector Update: Health Care Stocks Slipping Late Afternoon
MT
Top Midday Gainers
MT
Major US Banks' Lower Earnings Drag Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday
MT
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
AQ
PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission
CI
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K
PU
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
AQ
PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.
CI
Certain Common Stock of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.
CI
HC Wainwright Starts PaxMedica With Buy Rating, $3 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PXMD Stock
  4. News PaxMedica, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW